English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Genzyme Corporation
+
Technology/Innovation
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
+
Community
Carol Ostrow
| Sep 20, 2017
Sanofi partner Alnylam to suspend fitusiran trial for treating hemophilia
+
Community
Nicholas Gueguen
| Aug 4, 2017
Sanofi Genzyme observes Rare Disease Day globally
+
Technology/Innovation
Ruth de Jauregui
| May 7, 2017
Data from multiple sclerosis medication study shows promise
+
Technology/Innovation
Ruth de Jauregui
| May 7, 2017
Sanfoli Genzyme releases 6 years of data on Lemtrada in patients with relapsing remitting multiple sclerosis
+
Technology/Innovation
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
+
Community
Ruth de Jauregui
| Mar 29, 2017
Multiple Myeloma Journey Partners Program to expand
Robert Lawson
| Feb 19, 2017
Trial focuses on common genetic link to Parkinson's
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
